Inhibrx Biosciences, Inc. (INBX) at a glance

Inhibrx Biosciences, Inc. (INBX) is a small-cap Healthcare company. It trades at $124.22, with a P/E of 0.2 and a 0% profit margin. It does not pay a dividend. Vestovix scores it 54/100 overall. Its strongest dimension is Value (92/100) and its weakest is Safety (20/100). It carries above-market volatility, so expect larger swings.

Price

$124.23

Market cap

$1.35B

P/E ratio

0.2

Dividend yield

None

Beta

3.32

52-week range

$26.19 to $155.29